The haematopoietic myeloid growth factors GM- and G-CSF have been tested in the treatment of acute myelogenous leukaemia (AML) to see whether their application would increase chemosensitivity (leukaemia blast priming), would reduce the duration of therapy-induced bone marrow aplasia and would lower the rate of infections. Data today indicate that none of these objectives have consistently been met, although both GM- or G-CSF can safely be administered to AML patients. Whilst the mature results of a few ongoing trials must still be awaited, it is unlikely that growth factors will exert a significant impact on the current practice of AML treatment. Perhaps the most promising avenue in the near future is their use in the harvest of autologous peripheral blood stem cells within the setting of high-dose chemotherapy consolidation in AML.

Keywords:
AML, G-CSF, GM-CSF, Growth factor, AML chemotherapy, Infections, Neutropenia
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.